Results 11 to 20 of about 3,229,409 (289)

Keratoconus progression associated with hormone replacement therapy

American Journal of Ophthalmology Case Reports, 2019
Purpose: To report a postmenopausal patient with keratoconus who experienced significant progression after using hormone replacement therapy. Observations: A 51-year-old woman with previously stable keratoconus presented with acute disease progression ...
Giulia Coco, Ahmad Kheirkhah, William Foulsham, Reza Dana, Joseph B. Ciolino   +4 more
doaj   +3 more sources

Hormone replacement therapy perspectives

Frontiers in Global Women's Health
Hormone replacement therapy (HRT), also known as menopausal hormone therapy (MHT), was looked upon as a fountain of youth that kept women young and reduced cardiovascular disease. This led to a large-scale study called the Women's Health Initiative (WHI)
Dohn Kissinger
doaj   +3 more sources

The Controversial History of Hormone Replacement Therapy

Medicina, 2019
The history of hormone replacement therapy (HRT) started in the 1960s, with very high popularity in the 1990s. The first clinical trials on HRT and chronic postmenopausal conditions were started in the USA in the late 1990s. After the announcement of the
Angelo Cagnacci, Martina Venier
doaj   +3 more sources

Thrombotic variables and risk of idiopathic venous thromboembolism in women aged 45-64 years - Relationships to hormone replacement therapy [PDF]

, 2000
Hormone replacement therapy (HRT) has been shown to increase the relative risk of idiopathic venous thromboembolism (VTE) about threefold in several observational studies and one randomised controlled trial. Whether or not this relative risk is higher in
Rumley, A., Daly, E., Gough, P., Woodward, M., Lowe, G., Vessey, M.   +5 more
core   +8 more sources

Hormone replacement therapy is associated with improved verbal declarative memory in healthy relatively recent postmenopausal women. [PDF]

, 2006
The efficacy of Hormone Replacement Therapy (HRT) for cognitive health in postmenopausal women has been systematically questioned during the last decade.
Sünram-Lea, Sandra I., Papavasiliou Evangelia, Papavasiliou, E., Sunram-Lea Sandra   +3 more
core   +5 more sources

Different effects of oral and transdermal hormone replacement therapies on Factor IX, APC resistance, t-PA, PAI and C- reactive protein - a cross-sectional population survey [PDF]

, 2001
The effects of hormone replacement therapy (HRT) on thrombosis risk, thrombotic variables, and the inflammatory marker C- reactive protein (CRP) may vary by route of administration (oral versus transdermal).
Lowe, G.D.O., Rumley, A., McConnachie, A., Upton, M.N., Watt, G.C.M., O'Reilly, D.S.   +5 more
core   +8 more sources

RETRACTED: Effect of Weekly Long-Acting Growth Hormone Replacement Therapy Compared to Daily Growth Hormone on Children With Short Stature: A Meta-Analysis

Frontiers in Endocrinology, 2021
BackgroundWe performed a meta-analysis to evaluate the efficacy and safety of weekly long-acting growth hormone replacement therapy compared to daily growth hormone in children with short stature.MethodsA systematic literature search up to April 2021 was
Liyan Ma, Liangyi Li, Wen Pan, Congfu Huang, Limei Liu, Xiaoxiao Zhang, Xiaoxiao Zhang   +6 more
doaj   +1 more source

Pregnancy Outcomes of Different Endometrial Preparation in Patients With a History of Cesarean Section

Frontiers in Endocrinology, 2022
ObjectiveTo investigate the efficacies of three cycle regimens in women receiving frozen embryo transfer with a history of cesarean section: natural cycle treatment, hormone replacement therapy and treatment with gonadotropin-releasing hormone agonist ...
Run Xin Gan, Run Xin Gan, Yuan Li, Yuan Li, Juan Song, Quan Wen, Quan Wen, Guang Xiu Lu, Guang Xiu Lu, Ge Lin, Ge Lin, Fei Gong, Fei Gong   +12 more
doaj   +1 more source

Hormone replacement therapy [PDF]

BMJ, 2012
A 51 year old woman presents to her general practitioner with troublesome hot flushes and night sweats for the past eight months. She is sexually active and her last period was about 5 months ago. She has taken a number of over-the-counter preparations, but none have been effective.
Hickey, M., Elliott, C., Davison, S.
openaire   +3 more sources

Serum levels of cancer antigen 125 before hormone replacement therapy are not associated with clinical outcome of frozen embryo transfer in women with adenomyosis

Journal of International Medical Research, 2021
Aim This retrospective study aimed to evaluate the predictive value of serum cancer antigen 125 (CA125) levels before hormone replacement therapy on pregnancy outcomes in women with adenomyosis undergoing frozen embryo transfer.
Ling Huang, Yubin Li, Minghui Chen, Zengyan Wang, Canquan Zhou   +4 more
doaj   +1 more source